Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic obstructive pulmonary disease.

N R Anthonisen1

  • 1Section of Respiratory Disease, University of Manitoba, Winnipeg.

CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne
|March 15, 1988
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genetic association between human chitinases and lung function in COPD.

Human genetics·2011
Same author

Geographical variations in the prevalence of atopic sensitization in six study sites across Canada.

Allergy·2010
Same author

Workers' compensation and mesothelioma.

Canadian respiratory journal·2009
Same author

Associations of IL6 polymorphisms with lung function decline and COPD.

Thorax·2009
Same author

Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD?

The European respiratory journal·2008
Same author

Association of genetic variations in the CSF2 and CSF3 genes with lung function in smoking-induced COPD.

The European respiratory journal·2008
Same journal

Rheumatoid synovitis of the elbow mimicking rheumatoid nodule.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026
Same journal

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026
Same journal

What pool closures in Canada mean for health.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026
Same journal

Fatal rabies in a child.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026
Same journal

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026
Same journal

Otitis externa.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026
See all related articles

Effective outpatient management of chronic obstructive pulmonary disease (COPD) involves bronchodilators for most patients. Other treatments like antibiotics and oxygen are reserved for specific symptoms or conditions like hypoxemia.

Area of Science:

  • Pulmonology
  • Internal Medicine

Background:

  • Chronic obstructive pulmonary disease (COPD) management in outpatient settings requires a nuanced approach.
  • Established treatments and their efficacy in COPD require ongoing review.

Purpose of the Study:

  • To review current strategies for outpatient management of chronic obstructive pulmonary disease (COPD).
  • To evaluate the efficacy and indications for various therapeutic interventions in COPD patients.

Main Methods:

  • Literature review of studies on COPD outpatient management.
  • Analysis of evidence for pharmacological and non-pharmacological interventions.

Main Results:

  • Bronchodilator therapy, particularly beta 2-agonists, is indicated for most COPD patients.

Related Experiment Videos

  • Antibiotics are beneficial for symptomatic exacerbations; systemic corticosteroids are for a subset of patients.
  • Continuous oxygen therapy is crucial for chronic arterial hypoxemia; cor pulmonale management involves diuretics and oxygen.
  • Conclusions:

    • Bronchodilators offer significant benefits beyond symptom relief in COPD.
    • Targeted use of antibiotics, corticosteroids, and oxygen therapy is essential for managing COPD exacerbations and complications.
    • Smoking cessation importance is noted, though benefit in established COPD is unproven.